Milestone Pharmaceuticals downgraded by Jefferies with a new price target

6/20/23 7:40:01 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Jefferies downgraded Milestone Pharmaceuticals from Buy to Hold and set a new price target of $4.00 from $8.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MIST

Date	Price Target	Rating	Analyst
6/5/2025	$5.00	Buy	H.C. Wainwright
8/22/2024	$9.00	Buy	Rodman & Renshaw
6/20/2023	$8.00 → $4.00	Buy → Hold	Jefferies
4/22/2022	$8.00 → $10.00	Neutral → Overweight	Piper Sandler